Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthetic lethality between TP53 and ENDOD1. | Nat Commun | 2022 | 35606358 | PubTator, text mining | PubMed |
| Inherited bone marrow failure in the pediatric patient. | Blood | 2022 | 35605178 | PubTator, text mining | PubMed |
| The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma. | PeerJ | 2022 | 35602894 | PubTator, text mining | PubMed |
A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimen. | Med Oncol | 2022 | 35599264 | PubTator, text mining | PubMed |
| De Novo myelodysplastic syndromes in patients 20-50 years old are enriched for adverse risk features. | Leuk Res | 2022 | 35598475 | PubTator, text mining | PubMed |
| VIPPID: a gene-specific single nucleotide variant pathogenicity prediction tool for primary immunodeficiency diseases. | Brief Bioinform | 2022 | 35598327 | PubTator, text mining | PubMed |
| Correction: Identification of deleterious variants in patients with male infertility due to idiopathic non-obstructive azoospermia. | Reprod Biol Endocrinol | 2022 | 35596230 | PubTator, text mining | PubMed |
| Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variants. | Sci Rep | 2022 | 35595798 | PubTator, text mining | PubMed |
| Distinct landscapes of deleterious variants in DNA damage repair system in ethnic human populations. | Life Sci Alliance | 2022 | 35595529 | PubTator, text mining | PubMed |
| Concise Synthesis of Tunicamycin V and Discovery of a Cytostatic DPAGT1 Inhibitor. | Angew Chem Int Ed Engl | 2022 | 35594368 | PubTator, text mining | PubMed |
| DNA damage and repair in the hematopoietic system. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35593466 | PubTator, text mining | PubMed |
| Genetic differentiation in East African ethnicities and its relationship with endurance running success. | PLoS One | 2022 | 35588128 | PubTator, text mining | PubMed |
| A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response. | Cell Rep Med | 2022 | 35584624 | PubTator, text mining | PubMed |
| Skin Cancer-Associated S. aureus Strains Can Induce DNA Damage in Human Keratinocytes by Downregulating DNA Repair and Promoting Oxidative Stress. | Cancers (Basel) | 2022 | 35565272 | PubTator, text mining | PubMed |
| Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment. | Cells | 2022 | 35563772 | PubTator, text mining | PubMed |
| MicroRNA-449a Inhibits Triple Negative Breast Cancer by Disturbing DNA Repair and Chromatid Separation. | Int J Mol Sci | 2022 | 35563522 | PubTator, text mining | PubMed |
| Oxidative Stress and Chemoradiation-Induced Oral Mucositis: A Scoping Review of In Vitro, In Vivo and Clinical Studies. | Int J Mol Sci | 2022 | 35563254 | PubTator, text mining | PubMed |
| Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients. | Int J Mol Sci | 2022 | 35563100 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors. | Sci Adv | 2022 | 35559673 | PubTator, text mining | PubMed |
| Fast B1 Mapping Based on Double-Angle Method with T1 Correction Using Standard Pulse Sequence. | J Med Phys | 2022 | 35548043 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=46